Rosella Petraroli

Emea Market Development Leader - Clinical Next Generation Sequencing Division @Thermo Fisher Scientific

Rome, IT
MOBILE NUMBERS
+91 *********19

Signup · Get unlimited contacts

WORK HISTORY

Jan 2021 — Present

Emea Market Development Leader - Clinical Next Generation Sequencing Division @Thermo Fisher Scientific

View department →

Rome, IT

Leading a team of Market Development Managers to support revenue and growth goals for the Clinical Next Generation Sequencing division in Oncology, Hematology, Infectious Disease and Reproductive Health market. Development of metrics and KPI framework that enables informed business decision and support NPIs launch excellence. Passionate on enabling strong KOLs relationship to sustain a customer centric market knowledge and a product development roadmap that includes EMEA market needs

EDUCATION

2015 — 2015

University of California, Irvine Division of Continuing Education

Digital Marketing

SKILLS

SequencingBiotechnologyCommercializationOncologyGenomicsMolecular DiagnosticsQpcrCross-Functional Team LeadershipDnaDna SequencingLaboratory AutomationStrategyLifesciencesProduct LaunchMolecular BiologyAssay Development

ABOUT ROSELLA PETRAROLI

As the Market Development leader of EMEA Clinical Next Generation Sequencing division at Thermo Fisher Scientific, I lead the portfolio of the NGS clinical solutions in Oncology, Hemato-Oncology, Reproductive health and infectious disease for laboratories and healthcare providers across EMEA. With over 25 years of experience in clinical and life science businesses, I am passionate about working as one team with different functions driving demand and market adoption building and leveraging one company value proposition for clinical oncology and reproductive health customers. My personal mission is about creating an inclusive workplace culture where everyone can experience their fullest potential and the joy of teamwork. In the last 5 years I have transformed the Market development strategy and execution for the next generation sequencing business reorganizing the team from product focus to biomarker impact and patient outcome marketing driving every year double digit growth.I’m personally driven by continuous learning for both myself and my teams.Strengths: Grit, Developer, Positivity, Ideation, Adaptability

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.

Rosella Petraroli — Emea Market Development Leader - Clinical Next Generation Sequencing Division at Thermo Fisher Scientific in Rome, IT | Unifers